ABBV Gross Margin
Percentage of revenue retained after cost of goods sold.
Gross Margin
Latest: 74.7% (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | 60.9% |
| 2020Q4 | 66.2% |
| 2021Q1 | 67.6% |
| 2021Q2 | 67.6% |
| 2021Q3 | 69.4% |
| 2021Q4 | 71.0% |
| 2022Q1 | 70.1% |
| 2022Q2 | 71.4% |
| 2022Q3 | 66.1% |
| 2022Q4 | 72.4% |
| 2023Q1 | 67.4% |
| 2023Q2 | 69.4% |
| 2023Q3 | 68.7% |
| 2023Q4 | 70.8% |
| 2024Q1 | 66.7% |
| 2024Q2 | 70.9% |
| 2024Q3 | 70.9% |
| 2024Q4 | 70.9% |
| 2025Q1 | 70.0% |
| 2025Q2 | 71.8% |
| 2025Q3 | 66.4% |
| 2025Q4 | 72.6% |
| 2026Q1 | 71.9% |
| 2026Q2 | 74.7% |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Gross Margin
Gross Margin
Gross Margin
Latest Gross Margin: 74.7% (2026Q2); +2.9 pp YoY.
Across the 54 quarters from 2013Q1 to 2026Q2, Gross Margin ranged from 60.9% in 2020Q3 to 83.3% in 2015Q2.
Chart and table show the latest 24 of 54 quarters.